2014 Annual Multidisciplinary European Phenylketonuria Symposium: PKU a lifetime of challenges

Aims of the symposium

Download final programme and abstracts

Phenylketonuria (PKU) is still a challenge for clinicians and researchers. Dietary restriction of phenylalanine (Phe) remains the main therapy, with some patients being suitable for medical treatment with sapropterin. Today’s research  is  focusing  on  the  pathophysiology  of  this  disease,  on  its neurocognitive impact, on its appropriate management and on possible new therapies.  Ongoing  work  by  many  scientists  is  leading  towards  the development of evidence-based European guidelines that will provide the best standard of care to all patients with PKU. This symposium will review the most important research achievements in this field, and provide a unique opportunity to share knowledge and best practice in the clinical management of PKU.

Learning objectives

After attending this live educational symposium, learners will have up-to- date knowledge about the latest developments in research and clinical management of PKU, and will be able to:

• Evaluate challenges and solutions in the management of PKU, including diet and medical therapy, and possible future treatments
• Interpret  the  pathophysiological  insights  into  the  disease  and  its neurocognitive repercussion on patients, and compare ways to counteract such events
• Consider  the  best  approaches  for  management  of  special  clinical conditions, such as maternal PKU or transition age and adulthood
• Discuss the development of European guidelines for the management and best care of PKU

Target audience

Paediatricians and specialists in inherited metabolic diseases, dietitians and nutritionists, scientists and all other healthcare professional involved in diagnosing or managing PKU.

Accreditation

EXCEMED (www.excemed.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ^® ) to provide the following CME activity for medical specialists. The EACCME ^® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The CME ‘2014 Annual Multidisciplinary European Phenylketonuria Symposium - PKU: a lifetime of challenges’ held on 6 – 7 June 2014 in Zagreb, Croatia, is designated for a maximum of 9 (nine) hours of European CME credits (ECMEC ^® ). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ^® credits are recognised by the American Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ^® credit to AMA PRA category 1 credit, please contact the AMA.

EXCEMED adheres to the principles of the Good CME Practice Group (gCMEp).